These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34925247

  • 1. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study.
    Ceccato F, Tizianel I, Voltan G, Maggetto G, Merante Boschin I, Quaia E, Crimì F, Scaroni C.
    Front Endocrinol (Lausanne); 2021; 12():794197. PubMed ID: 34925247
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
    Sane T, Schalin-Jäntti C, Raade M.
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
    [Abstract] [Full Text] [Related]

  • 4. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, Pelusi C, Gambineri A, Altieri P, Mosconi C, Balacchi C, Golfieri R, Cosentino ER, Borghi C, Vicennati V, Pasquali R, Pagotto U.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5519-5528. PubMed ID: 31381072
    [Abstract] [Full Text] [Related]

  • 5. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Pelsma I, Marina L, Lorenz K, Bancos I, Arlt W, Dekkers OM.
    Eur J Endocrinol; 2023 Jul 20; 189(1):G1-G42. PubMed ID: 37318239
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
    Olsen H, Nordenström E, Bergenfelz A, Nyman U, Valdemarsson S, Palmqvist E.
    Endocrine; 2012 Aug 20; 42(1):164-73. PubMed ID: 22350586
    [Abstract] [Full Text] [Related]

  • 10. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
    Olmos R, Mertens N, Vaidya A, Uslar T, Fernandez P, Guarda FJ, Zúñiga Á, San Francisco I, Huete A, Baudrand R.
    J Clin Endocrinol Metab; 2022 Apr 19; 107(5):e1946-e1953. PubMed ID: 35020922
    [Abstract] [Full Text] [Related]

  • 11. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A.
    Clin Endocrinol (Oxf); 1998 Jan 19; 48(1):89-97. PubMed ID: 9509073
    [Abstract] [Full Text] [Related]

  • 12. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
    Araujo-Castro M, Mínguez Ojeda C, Sánchez Ramírez MN, Gómez Dos Santos V, Pascual-Corrrales E, Fernández-Argüeso M.
    Endocrine; 2022 Oct 19; 78(1):142-150. PubMed ID: 35751779
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study.
    Di Dalmazi G, Vicennati V, Pizzi C, Mosconi C, Tucci L, Balacchi C, Cosentino ER, Paolisso P, Fanelli F, Gambineri A, Pelusi C, Repaci A, Garelli S, Galiè N, Borghi C, Golfieri R, Pagotto U.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32413902
    [Abstract] [Full Text] [Related]

  • 14. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr 01; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 15. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM.
    Eur J Endocrinol; 2016 Aug 01; 175(2):G1-G34. PubMed ID: 27390021
    [Abstract] [Full Text] [Related]

  • 16. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H, Kranz S, Morell SM, Altieri B, Kroiss M, Detomas M, Fassnacht M, Deutschbein T.
    Front Endocrinol (Lausanne); 2023 Aug 01; 14():1123132. PubMed ID: 37223045
    [Abstract] [Full Text] [Related]

  • 17. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M, García Cano AM, Escobar-Morreale HF, Valderrabano P.
    Hormones (Athens); 2023 Mar 01; 22(1):51-59. PubMed ID: 36279032
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.